Cubist Systematic Strategies LLC Has $898,000 Position in American Vanguard Co. (NYSE:AVD)

Cubist Systematic Strategies LLC boosted its stake in shares of American Vanguard Co. (NYSE:AVD - Free Report) by 264.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 193,846 shares of the basic materials company's stock after buying an additional 140,709 shares during the quarter. Cubist Systematic Strategies LLC owned approximately 0.67% of American Vanguard worth $898,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AVD. Barclays PLC lifted its holdings in American Vanguard by 59.3% during the 3rd quarter. Barclays PLC now owns 73,112 shares of the basic materials company's stock worth $388,000 after buying an additional 27,229 shares during the period. JPMorgan Chase & Co. lifted its holdings in American Vanguard by 20.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 298,898 shares of the basic materials company's stock worth $1,584,000 after buying an additional 50,230 shares during the period. Ieq Capital LLC acquired a new position in American Vanguard during the 4th quarter worth about $54,000. Proficio Capital Partners LLC bought a new position in shares of American Vanguard in the 4th quarter worth about $94,000. Finally, PNC Financial Services Group Inc. raised its position in shares of American Vanguard by 133.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 6,575 shares of the basic materials company's stock worth $30,000 after acquiring an additional 3,753 shares in the last quarter. 79.04% of the stock is owned by institutional investors and hedge funds.

American Vanguard Stock Performance

AVD stock opened at $4.23 on Thursday. The stock has a 50-day moving average price of $4.22 and a 200-day moving average price of $4.97. American Vanguard Co. has a 1-year low of $3.28 and a 1-year high of $9.84. The company has a current ratio of 1.89, a quick ratio of 0.79 and a debt-to-equity ratio of 0.55. The firm has a market cap of $121.77 million, a PE ratio of -4.11 and a beta of 1.24.

Analysts Set New Price Targets

Separately, Lake Street Capital set a $14.00 price objective on American Vanguard in a research report on Tuesday, January 21st.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.